After setting up more than $30 billion in medtech M&A spending within less than two years, Johnson & Johnson CEO Joaquin ...

The Schockwave deal is expected to boost sales and be accretive to operating margin for J&J and its J&J MedTech unit, ...

Abbott (NYSE: ABT) shares fell this morning despite first-quarter results that came in ahead of the consensus forecast.

Balloon Catheter Market with an anticipated compound annual growth rate (CAGR) of 4.3%, is projected to reach US$ 6.4 billion ...

Global Atrial Fibrillation Market generated revenue of US$ 3,310.1 million in 2022 and is estimated to reach a valuation of US$ 6,839.8 million by 2031 at a CAGR of 8.71% during the forecast period, ...

Good Value Marketing Company (GVMC) manufactures and markets hi-tech organic manures. Good Value came out with a Rs 0.99-cr rights-cum-public issue to finance the expansion-cum-modernisation of its ...

Request To Download Free Sample of This Strategic Report @- Cardiac mapping Market is valued approximately at USD 1.3 ...

In the section titled "Full-Year 2024 Guidance", in the table, row titled "Operational Sales2,5/ Mid-point", the numbers for the April 2024 column should read: $88.7B – $89.1B / $88.9B (instead of: ...

Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2024. "Johnson & Johnson's solid first quarter performance reflects our sharpened focus ...